Chemotherapy (Cisplatin)

DRUG3 trials

Sponsors

Insel Gruppe AG, University Hospital Bern, Gustave Roussy, Cancer Campus, Grand Paris, Guangdong Association of Clinical Trials

Conditions

Gynecologic CancerHead and Neck NeoplasmsNon Small Cell Lung Cancer

Phase 1

AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy

Gustave Roussy, Cancer Campus, Grand ParisGynecologic Cancer

Start: 2018-05-17End: 2024-05-31Target: 18Updated: 2021-07-07

Phase 2

A Exploratory Study of Nivolumab Monotherapy or in Combination With Nab-paclitaxel and Carboplatin in Early Stage NSCLC in China

Active, not recruitingNCT04015778

Guangdong Association of Clinical TrialsNon Small Cell Lung Cancer

Start: 2019-08-08End: 2026-08-30Target: 316Updated: 2026-05-20

Phase 3

Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Dissection

CompletedNCT02918955

Insel Gruppe AG, University Hospital BernHead and Neck Neoplasms

Start: 2016-12-16End: 2025-06-24Updated: 2025-11-20

Related Papers

Molecular profiling of neoadjuvant immunochemotherapy and identification of residual cancer cells in pCR NSCLC: A single-cell analysis of CTONG 1804 clinical trial.

Journal of Clinical Oncology2025-05-28

Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.

2023-12-0632 citations

Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)

BMC Cancer2023-04-1549 citations

LBA2 Phase II study of PD-L1 expression guidance on neoadjuvant (NA) nivolumab (Nivo) monotherapy with or without platinum-doublet chemotherapy in resectable NSCLC

Immuno-Oncology Technology2022-12-013 citations